Skip to main content
Clinical Trials/NCT05829941
NCT05829941
Not Yet Recruiting
N/A

Technology Assisted Treatment for Binge Eating Behavior

HabitAware Inc.0 sites30 target enrollmentDecember 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Binge-Eating Disorder
Sponsor
HabitAware Inc.
Enrollment
30
Primary Endpoint
Percentage of patients in the HabitAware condition that report the treatment is acceptable.
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Binge-eating behavior is a central feature of eating disorders (e.g., binge-eating disorder, bulimia nervosa, anorexia nervosa-binge-eating/purging subtype) and is associated with higher rates of psychopathology, psychosocial impairment, medical comorbidity, and more severe obesity, all of which pose significant public health problems. Passive detection of binge eating episodes combined with a context-based reminder intervention could assist a patient in resuming healthy eating patterns. This study will test a smartwatch app that identifies binge eating behavior and provides CBT strategies to the patient after the episode.

Registry
clinicaltrials.gov
Start Date
December 2024
End Date
August 2025
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults ≥18 years of age
  • EDE diagnosis of bulimia nervosa or binge eating disorder, with binge-eating episodes occurring at least 2x/week

Exclusion Criteria

  • Pregnancy or lactation
  • Acute medical or psychiatric risk
  • Psychosis or bipolar disorder (lifetime history)
  • Current substance use disorder within the past six months
  • BMI less than 18.5 kg/m2
  • Acute suicidality requiring hospitalization
  • Food allergies
  • Receiving current psychotherapy
  • On psychotropic medications that have not been on a stable dose for at least six weeks

Outcomes

Primary Outcomes

Percentage of patients in the HabitAware condition that report the treatment is acceptable.

Time Frame: 8 weeks

Measured via post-treatment survey

Secondary Outcomes

  • Percentage of patients report that the binge episode detection is accurate(8 weeks)

Similar Trials